Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.66070046 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.66070046 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.35551866 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.35551866 |
5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.30461689 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 6.25807841 |
7 | tryptophan catabolic process (GO:0006569) | 5.88758286 |
8 | indole-containing compound catabolic process (GO:0042436) | 5.88758286 |
9 | indolalkylamine catabolic process (GO:0046218) | 5.88758286 |
10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.82622842 |
11 | kynurenine metabolic process (GO:0070189) | 5.73425490 |
12 | urea metabolic process (GO:0019627) | 5.69099391 |
13 | urea cycle (GO:0000050) | 5.69099391 |
14 | bile acid biosynthetic process (GO:0006699) | 5.56601774 |
15 | tryptophan metabolic process (GO:0006568) | 5.54499194 |
16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.51984506 |
17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.36755389 |
18 | sulfur amino acid catabolic process (GO:0000098) | 5.32857156 |
19 | nitrogen cycle metabolic process (GO:0071941) | 5.18315016 |
20 | glyoxylate metabolic process (GO:0046487) | 5.16511737 |
21 | complement activation, alternative pathway (GO:0006957) | 5.12426573 |
22 | cysteine metabolic process (GO:0006534) | 5.10346227 |
23 | bile acid and bile salt transport (GO:0015721) | 5.06671677 |
24 | regulation of protein activation cascade (GO:2000257) | 5.05533998 |
25 | negative regulation of fibrinolysis (GO:0051918) | 5.03768391 |
26 | regulation of triglyceride catabolic process (GO:0010896) | 5.02308225 |
27 | bile acid metabolic process (GO:0008206) | 4.94379837 |
28 | regulation of cholesterol esterification (GO:0010872) | 4.93636315 |
29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.92443884 |
30 | protein carboxylation (GO:0018214) | 4.92443884 |
31 | reverse cholesterol transport (GO:0043691) | 4.90465066 |
32 | regulation of fibrinolysis (GO:0051917) | 4.88306046 |
33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87801449 |
34 | phospholipid efflux (GO:0033700) | 4.84404867 |
35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83212648 |
36 | protein-lipid complex remodeling (GO:0034368) | 4.83212648 |
37 | macromolecular complex remodeling (GO:0034367) | 4.83212648 |
38 | homocysteine metabolic process (GO:0050667) | 4.77916441 |
39 | negative regulation of cholesterol transport (GO:0032375) | 4.75966420 |
40 | negative regulation of sterol transport (GO:0032372) | 4.75966420 |
41 | regulation of complement activation (GO:0030449) | 4.71639733 |
42 | serine family amino acid catabolic process (GO:0009071) | 4.64891444 |
43 | amino-acid betaine metabolic process (GO:0006577) | 4.52580491 |
44 | aromatic amino acid family metabolic process (GO:0009072) | 4.47204253 |
45 | intestinal cholesterol absorption (GO:0030299) | 4.42762311 |
46 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.41678613 |
47 | cholesterol efflux (GO:0033344) | 4.40423102 |
48 | plasma lipoprotein particle assembly (GO:0034377) | 4.40176784 |
49 | acylglycerol homeostasis (GO:0055090) | 4.39609645 |
50 | triglyceride homeostasis (GO:0070328) | 4.39609645 |
51 | cellular glucuronidation (GO:0052695) | 4.37774385 |
52 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.33249197 |
53 | lysine metabolic process (GO:0006553) | 4.30918509 |
54 | lysine catabolic process (GO:0006554) | 4.30918509 |
55 | neutrophil activation involved in immune response (GO:0002283) | 4.30830521 |
56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.25605562 |
57 | regulation of gamma-delta T cell activation (GO:0046643) | 4.25098312 |
58 | drug catabolic process (GO:0042737) | 4.23163227 |
59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22781329 |
60 | positive regulation of B cell differentiation (GO:0045579) | 4.22586037 |
61 | tyrosine metabolic process (GO:0006570) | 4.20633568 |
62 | alpha-amino acid catabolic process (GO:1901606) | 4.20518012 |
63 | indolalkylamine metabolic process (GO:0006586) | 4.13569741 |
64 | plasma lipoprotein particle clearance (GO:0034381) | 4.12231866 |
65 | benzene-containing compound metabolic process (GO:0042537) | 4.05023517 |
66 | cellular biogenic amine catabolic process (GO:0042402) | 4.04321931 |
67 | amine catabolic process (GO:0009310) | 4.04321931 |
68 | imidazole-containing compound metabolic process (GO:0052803) | 4.03622521 |
69 | glycine metabolic process (GO:0006544) | 4.03276468 |
70 | low-density lipoprotein particle remodeling (GO:0034374) | 4.02328803 |
71 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.01919679 |
72 | phospholipid homeostasis (GO:0055091) | 3.95866776 |
73 | flavonoid metabolic process (GO:0009812) | 3.94697288 |
74 | protein-lipid complex assembly (GO:0065005) | 3.94461549 |
75 | cholesterol homeostasis (GO:0042632) | 3.93958233 |
76 | ethanol oxidation (GO:0006069) | 3.92908922 |
77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.92659823 |
78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.92659823 |
79 | regulation of bile acid biosynthetic process (GO:0070857) | 3.89641597 |
80 | cellular amino acid catabolic process (GO:0009063) | 3.88452789 |
81 | cellular ketone body metabolic process (GO:0046950) | 3.88233548 |
82 | sterol homeostasis (GO:0055092) | 3.88160071 |
83 | glutamate metabolic process (GO:0006536) | 3.84313022 |
84 | serine family amino acid metabolic process (GO:0009069) | 3.83581651 |
85 | plasma lipoprotein particle organization (GO:0071827) | 3.82412641 |
86 | glucuronate metabolic process (GO:0019585) | 3.81301072 |
87 | uronic acid metabolic process (GO:0006063) | 3.81301072 |
88 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.80817004 |
89 | cellular modified amino acid catabolic process (GO:0042219) | 3.77431067 |
90 | positive regulation of lipid catabolic process (GO:0050996) | 3.76123076 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 3.75559442 |
92 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.75087789 |
93 | negative regulation of cell killing (GO:0031342) | 3.75087789 |
94 | blood coagulation, intrinsic pathway (GO:0007597) | 3.73262941 |
95 | lipoprotein metabolic process (GO:0042157) | 3.72974998 |
96 | coenzyme catabolic process (GO:0009109) | 3.72906927 |
97 | fibrinolysis (GO:0042730) | 3.71044386 |
98 | arginine metabolic process (GO:0006525) | 3.70371426 |
99 | regulation of cholesterol homeostasis (GO:2000188) | 3.67937228 |
100 | negative regulation of lipase activity (GO:0060192) | 3.64034753 |
101 | drug transmembrane transport (GO:0006855) | 3.62479185 |
102 | protein-lipid complex subunit organization (GO:0071825) | 3.59595030 |
103 | response to peptidoglycan (GO:0032494) | 3.57463818 |
104 | response to nitrosative stress (GO:0051409) | 3.55541811 |
105 | negative regulation of interleukin-12 production (GO:0032695) | 3.55480544 |
106 | protein activation cascade (GO:0072376) | 3.53841559 |
107 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.52187872 |
108 | modulation by symbiont of host immune response (GO:0052553) | 3.52187872 |
109 | positive regulation by symbiont of host defense response (GO:0052509) | 3.52187872 |
110 | modulation by symbiont of host defense response (GO:0052031) | 3.52187872 |
111 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.52187872 |
112 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.52187872 |
113 | immunoglobulin mediated immune response (GO:0016064) | 3.51773627 |
114 | intestinal absorption (GO:0050892) | 3.50467363 |
115 | cytolysis (GO:0019835) | 3.49698198 |
116 | complement activation, classical pathway (GO:0006958) | 3.48929945 |
117 | exogenous drug catabolic process (GO:0042738) | 3.45976378 |
118 | acute-phase response (GO:0006953) | 3.45545606 |
119 | complement activation (GO:0006956) | 3.45200194 |
120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.44263347 |
121 | regulation of B cell differentiation (GO:0045577) | 3.42241196 |
122 | negative thymic T cell selection (GO:0045060) | 3.39921919 |
123 | cellular extravasation (GO:0045123) | 3.37279556 |
124 | detection of other organism (GO:0098543) | 3.36170648 |
125 | negative T cell selection (GO:0043383) | 3.31262789 |
126 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28449130 |
127 | microglial cell activation (GO:0001774) | 3.24330167 |
128 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.24092697 |
129 | B cell mediated immunity (GO:0019724) | 3.23772463 |
130 | response to interleukin-15 (GO:0070672) | 3.21196681 |
131 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.20313330 |
132 | detection of molecule of bacterial origin (GO:0032490) | 3.18584431 |
133 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.15822840 |
134 | leukocyte aggregation (GO:0070486) | 3.12641902 |
135 | macrophage activation involved in immune response (GO:0002281) | 3.11672940 |
136 | B cell receptor signaling pathway (GO:0050853) | 3.11475952 |
137 | positive regulation of granulocyte differentiation (GO:0030854) | 3.11074893 |
138 | positive thymic T cell selection (GO:0045059) | 3.10470735 |
139 | detection of bacterium (GO:0016045) | 3.08715467 |
140 | detection of external biotic stimulus (GO:0098581) | 3.06576307 |
141 | T cell migration (GO:0072678) | 3.04412517 |
142 | positive regulation of mast cell activation (GO:0033005) | 2.99155176 |
143 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.93305989 |
144 | definitive hemopoiesis (GO:0060216) | 2.92578259 |
145 | regulation of mast cell degranulation (GO:0043304) | 2.92309049 |
146 | neutrophil activation (GO:0042119) | 2.91252255 |
147 | myeloid cell activation involved in immune response (GO:0002275) | 2.90661568 |
148 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.87554074 |
149 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.87171461 |
150 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.82154012 |
151 | response to host immune response (GO:0052572) | 2.82154012 |
152 | detection of biotic stimulus (GO:0009595) | 2.80825540 |
153 | defense response to protozoan (GO:0042832) | 2.78996372 |
154 | response to muramyl dipeptide (GO:0032495) | 2.76535487 |
155 | positive T cell selection (GO:0043368) | 2.74089328 |
156 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.73422289 |
157 | macrophage activation (GO:0042116) | 2.73105932 |
158 | negative regulation of T cell mediated immunity (GO:0002710) | 2.73095086 |
159 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.72116686 |
160 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70374531 |
161 | granulocyte activation (GO:0036230) | 2.69697524 |
162 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.68394159 |
163 | positive regulation of interferon-alpha production (GO:0032727) | 2.66532176 |
164 | regulation of hypersensitivity (GO:0002883) | 2.65211542 |
165 | response to protozoan (GO:0001562) | 2.65116446 |
166 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.64373280 |
167 | regulation of mast cell activation (GO:0033003) | 2.63136412 |
168 | regulation of interferon-alpha production (GO:0032647) | 2.62674282 |
169 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.61583861 |
170 | Peyers patch development (GO:0048541) | 2.60229965 |
171 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.60229965 |
172 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.58850349 |
173 | regulation of regulatory T cell differentiation (GO:0045589) | 2.56913832 |
174 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56358267 |
175 | positive regulation of mast cell degranulation (GO:0043306) | 2.56358267 |
176 | positive regulation of humoral immune response (GO:0002922) | 2.55864440 |
177 | T cell selection (GO:0045058) | 2.55318424 |
178 | cellular response to interleukin-15 (GO:0071350) | 2.54683581 |
179 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.54186541 |
180 | positive regulation of B cell mediated immunity (GO:0002714) | 2.54186541 |
181 | respiratory burst (GO:0045730) | 2.52628538 |
182 | regulation of leukocyte degranulation (GO:0043300) | 2.51963538 |
183 | cellular response to ethanol (GO:0071361) | 2.51892638 |
184 | mast cell activation (GO:0045576) | 2.49849646 |
185 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.49792182 |
186 | myeloid dendritic cell activation (GO:0001773) | 2.48602273 |
187 | regulation of granulocyte differentiation (GO:0030852) | 2.45850060 |
188 | positive regulation of isotype switching (GO:0045830) | 2.45320764 |
189 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.45099250 |
190 | regulation of B cell mediated immunity (GO:0002712) | 2.44430699 |
191 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43729854 |
192 | regulation of tolerance induction (GO:0002643) | 2.43217851 |
193 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.43168108 |
194 | leukocyte degranulation (GO:0043299) | 2.43159338 |
195 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.42202093 |
196 | response to host defenses (GO:0052200) | 2.41543085 |
197 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.41543085 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.83344195 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.82724737 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.74291856 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18194123 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.72877173 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.61962779 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.05250689 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.01323569 |
9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.78056863 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.58608530 |
11 | * MYB_26560356_Chip-Seq_TH2_Human | 2.72926213 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37831905 |
13 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.37368183 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34956834 |
15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.21556335 |
16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16808131 |
17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.11213184 |
18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06564213 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03448323 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02248728 |
21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01409680 |
22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1201451 |
23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99175642 |
24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.96705260 |
25 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.93469916 |
26 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84880317 |
27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.81709993 |
28 | MYC_22102868_ChIP-Seq_BL_Human | 1.78522700 |
29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73880792 |
30 | * MAF_26560356_Chip-Seq_TH1_Human | 1.70401702 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70070922 |
32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70051744 |
33 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.68702603 |
34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67272975 |
35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.64826196 |
36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.63736076 |
37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.62456282 |
38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58853680 |
39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57314772 |
40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57314754 |
41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55181714 |
42 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.54870029 |
43 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54488659 |
44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53938612 |
45 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53646712 |
46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50858289 |
47 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.49436459 |
48 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.44463437 |
49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41064969 |
50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36014632 |
51 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32178676 |
52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31357136 |
53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28405240 |
54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28064967 |
55 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.27392305 |
56 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24512887 |
57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21179609 |
58 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19324537 |
59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15863659 |
60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15652890 |
61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12775614 |
62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10639826 |
63 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10146156 |
64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09569162 |
65 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.05469613 |
66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04058302 |
67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01660630 |
68 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00435515 |
69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99897113 |
70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99659586 |
71 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99296042 |
72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98065901 |
73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97470693 |
74 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.96944249 |
75 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95602220 |
76 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94710355 |
77 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93830409 |
78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93629708 |
79 | MAF_26560356_Chip-Seq_TH2_Human | 0.93417392 |
80 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.92840470 |
81 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.92840470 |
82 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.92840470 |
83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92086463 |
84 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91535305 |
85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91031063 |
86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88927423 |
87 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87761745 |
88 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87403928 |
89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86845752 |
90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85265376 |
91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85193171 |
92 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85065526 |
93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84804026 |
94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84207501 |
95 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82090396 |
96 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.82013096 |
97 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81381601 |
98 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.80532115 |
99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79749227 |
100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79228417 |
101 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78692868 |
102 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78645415 |
103 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.78204557 |
104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77993225 |
105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77945368 |
106 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77512800 |
107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76833920 |
108 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.75937745 |
109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75751145 |
110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74012228 |
111 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.73739799 |
112 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.73396109 |
113 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.73106001 |
114 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.72907193 |
115 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.72093714 |
116 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.71316304 |
117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70626080 |
118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70174948 |
119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69216456 |
120 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.68762524 |
121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68664135 |
122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.67877577 |
123 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65868063 |
124 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65500395 |
125 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.63839504 |
126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63279027 |
127 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.63003654 |
128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61156038 |
129 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.60995315 |
130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60973019 |
131 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.60136217 |
132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60098567 |
133 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.60023324 |
134 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.58247972 |
135 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.56873222 |
136 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.56785482 |
137 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.55908447 |
138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55768437 |
139 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.54635270 |
140 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.52513290 |
141 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.52335952 |
142 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51265900 |
143 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.51226413 |
144 | MYB_26560356_Chip-Seq_TH1_Human | 0.50066349 |
145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.50013866 |
146 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.49665259 |
147 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.49235142 |
148 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.49217624 |
149 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.49217624 |
150 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47414670 |
151 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47381677 |
152 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.46617252 |
153 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.46390655 |
154 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.46337539 |
155 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46317829 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 7.68248697 |
2 | MP0002139_abnormal_hepatobiliary_system | 7.57050675 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.13281556 |
4 | MP0005365_abnormal_bile_salt | 5.84889380 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.98979947 |
6 | MP0003252_abnormal_bile_duct | 3.95510132 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.55153879 |
8 | MP0010329_abnormal_lipoprotein_level | 3.54273883 |
9 | MP0001666_abnormal_nutrient_absorption | 3.22805444 |
10 | MP0003303_peritoneal_inflammation | 3.19527296 |
11 | MP0009840_abnormal_foam_cell | 3.07695129 |
12 | MP0005671_abnormal_response_to | 2.55260226 |
13 | MP0001800_abnormal_humoral_immune | 2.51914763 |
14 | MP0005332_abnormal_amino_acid | 2.51276944 |
15 | MP0005083_abnormal_biliary_tract | 2.48591824 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.32626733 |
17 | MP0005000_abnormal_immune_tolerance | 2.32368319 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.28008274 |
19 | MP0002396_abnormal_hematopoietic_system | 2.25501604 |
20 | MP0002723_abnormal_immune_serum | 2.15670316 |
21 | MP0003763_abnormal_thymus_physiology | 2.14290617 |
22 | MP0002452_abnormal_antigen_presenting | 2.14013291 |
23 | MP0005397_hematopoietic_system_phenotyp | 2.12874458 |
24 | MP0001545_abnormal_hematopoietic_system | 2.12874458 |
25 | * MP0000609_abnormal_liver_physiology | 2.12005198 |
26 | MP0001790_abnormal_immune_system | 2.11709943 |
27 | MP0005387_immune_system_phenotype | 2.11709943 |
28 | MP0009278_abnormal_bone_marrow | 2.10054572 |
29 | MP0004019_abnormal_vitamin_homeostasis | 2.07993437 |
30 | MP0002420_abnormal_adaptive_immunity | 2.04928167 |
31 | MP0001819_abnormal_immune_cell | 2.03504732 |
32 | MP0000685_abnormal_immune_system | 1.99588355 |
33 | MP0003868_abnormal_feces_composition | 1.97649813 |
34 | MP0002118_abnormal_lipid_homeostasis | 1.94906284 |
35 | MP0002398_abnormal_bone_marrow | 1.86468749 |
36 | MP0003195_calcinosis | 1.84038929 |
37 | * MP0005319_abnormal_enzyme/_coenzyme | 1.80780457 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.80701580 |
39 | MP0009697_abnormal_copulation | 1.78832878 |
40 | MP0008057_abnormal_DNA_replication | 1.73776237 |
41 | MP0009333_abnormal_splenocyte_physiolog | 1.70302563 |
42 | MP0000716_abnormal_immune_system | 1.68933864 |
43 | MP0010234_abnormal_vibrissa_follicle | 1.68686203 |
44 | MP0000689_abnormal_spleen_morphology | 1.68180432 |
45 | MP0000465_gastrointestinal_hemorrhage | 1.66677759 |
46 | MP0002405_respiratory_system_inflammati | 1.64582230 |
47 | MP0001764_abnormal_homeostasis | 1.62984238 |
48 | MP0003183_abnormal_peptide_metabolism | 1.58545548 |
49 | MP0002722_abnormal_immune_system | 1.58532370 |
50 | MP0003172_abnormal_lysosome_physiology | 1.52728112 |
51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48709834 |
52 | MP0002429_abnormal_blood_cell | 1.43549525 |
53 | MP0009643_abnormal_urine_homeostasis | 1.40226895 |
54 | MP0001533_abnormal_skeleton_physiology | 1.36833888 |
55 | MP0003656_abnormal_erythrocyte_physiolo | 1.35160178 |
56 | MP0000703_abnormal_thymus_morphology | 1.33107912 |
57 | MP0004808_abnormal_hematopoietic_stem | 1.31752476 |
58 | MP0004264_abnormal_extraembryonic_tissu | 1.29506920 |
59 | * MP0000598_abnormal_liver_morphology | 1.22465232 |
60 | MP0005310_abnormal_salivary_gland | 1.22426649 |
61 | MP0009764_decreased_sensitivity_to | 1.17277520 |
62 | MP0001851_eye_inflammation | 1.15840633 |
63 | MP0000604_amyloidosis | 1.15449643 |
64 | MP0003186_abnormal_redox_activity | 1.08601901 |
65 | MP0005464_abnormal_platelet_physiology | 1.08524626 |
66 | MP0005451_abnormal_body_composition | 1.08288640 |
67 | * MP0008469_abnormal_protein_level | 1.05702892 |
68 | MP0005636_abnormal_mineral_homeostasis | 1.05695205 |
69 | MP0000858_altered_metastatic_potential | 1.04711097 |
70 | MP0009763_increased_sensitivity_to | 1.04077100 |
71 | MP0002006_tumorigenesis | 1.03434320 |
72 | MP0008004_abnormal_stomach_pH | 1.00840030 |
73 | MP0003705_abnormal_hypodermis_morpholog | 1.00815392 |
74 | MP0002998_abnormal_bone_remodeling | 1.00105590 |
75 | MP0005647_abnormal_sex_gland | 0.99809123 |
76 | MP0003011_delayed_dark_adaptation | 0.98280494 |
77 | MP0003828_pulmonary_edema | 0.96599284 |
78 | MP0002009_preneoplasia | 0.95713956 |
79 | * MP0009642_abnormal_blood_homeostasis | 0.91377427 |
80 | MP0003436_decreased_susceptibility_to | 0.91253559 |
81 | MP0002876_abnormal_thyroid_physiology | 0.90695628 |
82 | MP0005084_abnormal_gallbladder_morpholo | 0.90290168 |
83 | MP0009765_abnormal_xenobiotic_induced | 0.89672329 |
84 | MP0010368_abnormal_lymphatic_system | 0.87454475 |
85 | MP0003300_gastrointestinal_ulcer | 0.85282847 |
86 | MP0002254_reproductive_system_inflammat | 0.85134304 |
87 | MP0008260_abnormal_autophagy | 0.80988391 |
88 | MP0003448_altered_tumor_morphology | 0.80689991 |
89 | * MP0002019_abnormal_tumor_incidence | 0.80234339 |
90 | MP0004883_abnormal_blood_vessel | 0.79104907 |
91 | MP0005408_hypopigmentation | 0.78067935 |
92 | MP0010307_abnormal_tumor_latency | 0.74993029 |
93 | MP0010155_abnormal_intestine_physiology | 0.73793029 |
94 | MP0005376_homeostasis/metabolism_phenot | 0.73469012 |
95 | MP0001873_stomach_inflammation | 0.72269589 |
96 | MP0005410_abnormal_fertilization | 0.71940366 |
97 | MP0003724_increased_susceptibility_to | 0.70971166 |
98 | MP0004147_increased_porphyrin_level | 0.70713590 |
99 | MP0003718_maternal_effect | 0.70497292 |
100 | MP0005220_abnormal_exocrine_pancreas | 0.68891327 |
101 | MP0002078_abnormal_glucose_homeostasis | 0.67359024 |
102 | MP0005670_abnormal_white_adipose | 0.67214249 |
103 | MP0005334_abnormal_fat_pad | 0.67059197 |
104 | MP0002136_abnormal_kidney_physiology | 0.66503750 |
105 | MP0002166_altered_tumor_susceptibility | 0.65478538 |
106 | MP0005164_abnormal_response_to | 0.64049038 |
107 | MP0002971_abnormal_brown_adipose | 0.63350672 |
108 | MP0000343_altered_response_to | 0.63205153 |
109 | MP0001845_abnormal_inflammatory_respons | 0.62587730 |
110 | MP0005166_decreased_susceptibility_to | 0.62392040 |
111 | MP0002822_catalepsy | 0.61279215 |
112 | MP0003075_altered_response_to | 0.59735806 |
113 | MP0009053_abnormal_anal_canal | 0.59507847 |
114 | MP0006036_abnormal_mitochondrial_physio | 0.58312189 |
115 | MP0008873_increased_physiological_sensi | 0.58150504 |
116 | MP0001756_abnormal_urination | 0.57858170 |
117 | MP0005448_abnormal_energy_balance | 0.57497887 |
118 | MP0009785_altered_susceptibility_to | 0.55397445 |
119 | MP0002928_abnormal_bile_duct | 0.54584003 |
120 | MP0003638_abnormal_response/metabolism_ | 0.54566858 |
121 | MP0005266_abnormal_metabolism | 0.54357590 |
122 | MP0005025_abnormal_response_to | 0.53409524 |
123 | MP0001663_abnormal_digestive_system | 0.52927933 |
124 | MP0001853_heart_inflammation | 0.52037527 |
125 | MP0005535_abnormal_body_temperature | 0.51778011 |
126 | MP0004947_skin_inflammation | 0.50787437 |
127 | MP0002419_abnormal_innate_immunity | 0.50243370 |
128 | MP0001765_abnormal_ion_homeostasis | 0.50182419 |
129 | MP0008872_abnormal_physiological_respon | 0.46729542 |
130 | MP0000639_abnormal_adrenal_gland | 0.46606798 |
131 | MP0001835_abnormal_antigen_presentation | 0.46100279 |
132 | MP0004130_abnormal_muscle_cell | 0.45424442 |
133 | MP0003690_abnormal_glial_cell | 0.44773326 |
134 | MP0000477_abnormal_intestine_morphology | 0.43603574 |
135 | MP0006082_CNS_inflammation | 0.42199312 |
136 | MP0009115_abnormal_fat_cell | 0.40302500 |
137 | MP0003866_abnormal_defecation | 0.40173874 |
138 | MP0000249_abnormal_blood_vessel | 0.39508618 |
139 | MP0002132_abnormal_respiratory_system | 0.39363642 |
140 | MP0005075_abnormal_melanosome_morpholog | 0.39272142 |
141 | MP0003329_amyloid_beta_deposits | 0.39255178 |
142 | MP0008874_decreased_physiological_sensi | 0.39148082 |
143 | MP0005381_digestive/alimentary_phenotyp | 0.38554644 |
144 | MP0003953_abnormal_hormone_level | 0.38475426 |
145 | MP0003943_abnormal_hepatobiliary_system | 0.38205123 |
146 | MP0005058_abnormal_lysosome_morphology | 0.37978945 |
147 | MP0002135_abnormal_kidney_morphology | 0.37229967 |
148 | MP0009384_cardiac_valve_regurgitation | 0.36183747 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.01935272 |
2 | Deep venous thrombosis (HP:0002625) | 6.82503223 |
3 | Hypobetalipoproteinemia (HP:0003563) | 6.66334418 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.57548023 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.44201994 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 6.22333514 |
7 | Xanthomatosis (HP:0000991) | 5.87758822 |
8 | Complement deficiency (HP:0004431) | 5.10044804 |
9 | Hyperlipoproteinemia (HP:0010980) | 4.85701670 |
10 | Hypolipoproteinemia (HP:0010981) | 4.65154741 |
11 | Joint hemorrhage (HP:0005261) | 4.58677607 |
12 | Fat malabsorption (HP:0002630) | 4.57908106 |
13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54471839 |
14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.52488020 |
15 | Eczematoid dermatitis (HP:0000976) | 4.34230343 |
16 | Epidermoid cyst (HP:0200040) | 4.33454944 |
17 | Conjugated hyperbilirubinemia (HP:0002908) | 4.32868988 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26330112 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22706281 |
20 | Hyperammonemia (HP:0001987) | 4.20341771 |
21 | Recurrent abscess formation (HP:0002722) | 4.07515212 |
22 | Recurrent bacterial skin infections (HP:0005406) | 4.07436889 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06822890 |
24 | Myositis (HP:0100614) | 4.06730885 |
25 | Prolonged bleeding time (HP:0003010) | 4.06106795 |
26 | Stomatitis (HP:0010280) | 4.04334634 |
27 | T lymphocytopenia (HP:0005403) | 3.95307418 |
28 | Abnormality of methionine metabolism (HP:0010901) | 3.89541301 |
29 | Retrobulbar optic neuritis (HP:0100654) | 3.82490550 |
30 | Optic neuritis (HP:0100653) | 3.82490550 |
31 | Orchitis (HP:0100796) | 3.82467113 |
32 | Acanthocytosis (HP:0001927) | 3.79555804 |
33 | Abnormality of T cell number (HP:0011839) | 3.77197459 |
34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.76717990 |
35 | Hypercholesterolemia (HP:0003124) | 3.75477466 |
36 | Ketosis (HP:0001946) | 3.75244524 |
37 | Hyperglycinemia (HP:0002154) | 3.75124161 |
38 | Abnormality of complement system (HP:0005339) | 3.72429130 |
39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67717066 |
40 | Hyperglycinuria (HP:0003108) | 3.66622933 |
41 | Hypoalphalipoproteinemia (HP:0003233) | 3.61420253 |
42 | Recurrent fungal infections (HP:0002841) | 3.58115279 |
43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.57063683 |
44 | Abnormality of macrophages (HP:0004311) | 3.55547923 |
45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.49582088 |
46 | Abnormality of glycine metabolism (HP:0010895) | 3.49582088 |
47 | Hypoglycemic coma (HP:0001325) | 3.45118088 |
48 | Hyperbilirubinemia (HP:0002904) | 3.44991130 |
49 | Meningitis (HP:0001287) | 3.35366514 |
50 | Encephalitis (HP:0002383) | 3.34157869 |
51 | Steatorrhea (HP:0002570) | 3.24631505 |
52 | Hypochromic microcytic anemia (HP:0004840) | 3.18361220 |
53 | Spontaneous abortion (HP:0005268) | 3.18082002 |
54 | Obstructive lung disease (HP:0006536) | 3.16087499 |
55 | Chronic obstructive pulmonary disease (HP:0006510) | 3.16087499 |
56 | Panhypogammaglobulinemia (HP:0003139) | 3.14767854 |
57 | Recurrent viral infections (HP:0004429) | 3.14652092 |
58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.13674245 |
59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.10379255 |
60 | Spontaneous hematomas (HP:0007420) | 3.10315910 |
61 | Autoimmune hemolytic anemia (HP:0001890) | 3.06733980 |
62 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05199404 |
63 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.04486544 |
64 | Recurrent skin infections (HP:0001581) | 3.02375563 |
65 | Keratoconjunctivitis sicca (HP:0001097) | 2.98182764 |
66 | Abnormality of T cells (HP:0002843) | 2.95891994 |
67 | Mediastinal lymphadenopathy (HP:0100721) | 2.94838432 |
68 | Gastrointestinal infarctions (HP:0005244) | 2.92668121 |
69 | Purpura (HP:0000979) | 2.91326887 |
70 | Abnormality of the prostate (HP:0008775) | 2.91058436 |
71 | Arterial thrombosis (HP:0004420) | 2.88817847 |
72 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88141299 |
73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88141299 |
74 | Vasculitis (HP:0002633) | 2.82352743 |
75 | Myocardial infarction (HP:0001658) | 2.82002452 |
76 | Systemic lupus erythematosus (HP:0002725) | 2.80153274 |
77 | Poikilocytosis (HP:0004447) | 2.79480822 |
78 | Increased IgM level (HP:0003496) | 2.77365217 |
79 | Leukocytosis (HP:0001974) | 2.76782411 |
80 | Hepatocellular carcinoma (HP:0001402) | 2.74132388 |
81 | Keratoconjunctivitis (HP:0001096) | 2.74071000 |
82 | Autoimmune thrombocytopenia (HP:0001973) | 2.73591015 |
83 | Gingival bleeding (HP:0000225) | 2.73043158 |
84 | Glomerulonephritis (HP:0000099) | 2.69750447 |
85 | Abnormality of purine metabolism (HP:0004352) | 2.69440112 |
86 | Granulocytopenia (HP:0001913) | 2.69251832 |
87 | Menorrhagia (HP:0000132) | 2.60812008 |
88 | Malnutrition (HP:0004395) | 2.60647060 |
89 | Metabolic acidosis (HP:0001942) | 2.60390704 |
90 | Skin nodule (HP:0200036) | 2.57267052 |
91 | Abnormality of B cell number (HP:0010975) | 2.56737800 |
92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55178686 |
93 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.53151044 |
94 | Abnormality of serum amino acid levels (HP:0003112) | 2.53090820 |
95 | Ketoacidosis (HP:0001993) | 2.52318439 |
96 | Delayed CNS myelination (HP:0002188) | 2.51253564 |
97 | Petechiae (HP:0000967) | 2.49667260 |
98 | Joint swelling (HP:0001386) | 2.49045786 |
99 | Eosinophilia (HP:0001880) | 2.48132282 |
100 | Hemoptysis (HP:0002105) | 2.45826279 |
101 | Pulmonary infiltrates (HP:0002113) | 2.45795051 |
102 | Esophageal varix (HP:0002040) | 2.45354949 |
103 | Chest pain (HP:0100749) | 2.43560619 |
104 | Vascular calcification (HP:0004934) | 2.43482673 |
105 | Gingivitis (HP:0000230) | 2.43208549 |
106 | Agammaglobulinemia (HP:0004432) | 2.41954361 |
107 | Spastic diplegia (HP:0001264) | 2.40780585 |
108 | IgM deficiency (HP:0002850) | 2.39401855 |
109 | Gangrene (HP:0100758) | 2.38047366 |
110 | Thrombophlebitis (HP:0004418) | 2.37255199 |
111 | Increased mean platelet volume (HP:0011877) | 2.31024314 |
112 | Increased cerebral lipofuscin (HP:0011813) | 2.28862080 |
113 | Thrombocytosis (HP:0001894) | 2.28073319 |
114 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27519036 |
115 | Dicarboxylic aciduria (HP:0003215) | 2.27519036 |
116 | Pancreatitis (HP:0001733) | 2.26976887 |
117 | Abnormal gallbladder physiology (HP:0012438) | 2.26753947 |
118 | Cholecystitis (HP:0001082) | 2.26753947 |
119 | Cellulitis (HP:0100658) | 2.24516767 |
120 | Anorexia (HP:0002039) | 2.23741668 |
121 | Amyloidosis (HP:0011034) | 2.23374334 |
122 | Inflammation of the large intestine (HP:0002037) | 2.23208019 |
123 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23095650 |
124 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23095650 |
125 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23095650 |
126 | Urticaria (HP:0001025) | 2.22749881 |
127 | Sensorimotor neuropathy (HP:0007141) | 2.21688174 |
128 | Abnormal platelet volume (HP:0011876) | 2.19138528 |
129 | Acute lymphatic leukemia (HP:0006721) | 2.19094064 |
130 | Abnormality of eosinophils (HP:0001879) | 2.18824174 |
131 | Hypoglycemic seizures (HP:0002173) | 2.17433104 |
132 | Abnormality of T cell physiology (HP:0011840) | 2.15880973 |
133 | Lethargy (HP:0001254) | 2.15272122 |
134 | Gastrointestinal inflammation (HP:0004386) | 2.15230593 |
135 | B lymphocytopenia (HP:0010976) | 2.14790308 |
136 | Colitis (HP:0002583) | 2.14699745 |
137 | Vacuolated lymphocytes (HP:0001922) | 2.14625758 |
138 | Abnormality of proline metabolism (HP:0010907) | 2.13256147 |
139 | Hydroxyprolinuria (HP:0003080) | 2.13256147 |
140 | Nephritis (HP:0000123) | 2.12535103 |
141 | Cholelithiasis (HP:0001081) | 2.11781618 |
142 | Hemorrhage of the eye (HP:0011885) | 2.11449117 |
143 | Abnormal gallbladder morphology (HP:0012437) | 2.11386399 |
144 | Conjunctival telangiectasia (HP:0000524) | 2.10737504 |
145 | IgG deficiency (HP:0004315) | 2.10597911 |
146 | Increased serum ferritin (HP:0003281) | 2.10041149 |
147 | Cardiovascular calcification (HP:0011915) | 2.09981000 |
148 | Stomach cancer (HP:0012126) | 2.08239755 |
149 | Prostate neoplasm (HP:0100787) | 2.08190951 |
150 | Amaurosis fugax (HP:0100576) | 2.08025223 |
151 | Renal cortical cysts (HP:0000803) | 2.06726884 |
152 | Combined immunodeficiency (HP:0005387) | 2.06208690 |
153 | Acute hepatic failure (HP:0006554) | 2.04491736 |
154 | Irritability (HP:0000737) | 2.03889077 |
155 | Abnormality of the pleura (HP:0002103) | 2.03522643 |
156 | Late onset (HP:0003584) | 2.03373397 |
157 | Severe combined immunodeficiency (HP:0004430) | 2.03114443 |
158 | Neonatal onset (HP:0003623) | 2.01416281 |
159 | Gout (HP:0001997) | 2.00032399 |
160 | Mitral stenosis (HP:0001718) | 1.99176217 |
161 | Epistaxis (HP:0000421) | 1.97606888 |
162 | Generalized aminoaciduria (HP:0002909) | 1.96401038 |
163 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94169578 |
164 | Abnormal platelet function (HP:0011869) | 1.93351397 |
165 | Impaired platelet aggregation (HP:0003540) | 1.93351397 |
166 | Abnormality of iron homeostasis (HP:0011031) | 1.86974759 |
167 | Abnormality of vitamin metabolism (HP:0100508) | 1.85486606 |
168 | Pulmonary embolism (HP:0002204) | 1.83729266 |
169 | Elevated hepatic transaminases (HP:0002910) | 1.82760361 |
170 | Brushfield spots (HP:0001088) | 1.80639849 |
171 | Vomiting (HP:0002013) | 1.78903470 |
172 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76674064 |
173 | Abnormality of the gallbladder (HP:0005264) | 1.75009612 |
174 | Reticulocytosis (HP:0001923) | 1.74995714 |
175 | Opisthotonus (HP:0002179) | 1.74097097 |
176 | Alkalosis (HP:0001948) | 1.72988782 |
177 | Hypertriglyceridemia (HP:0002155) | 1.72139997 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAOK3 | 5.06835152 |
2 | BCKDK | 4.82767825 |
3 | ERN1 | 3.90136586 |
4 | FGFR4 | 3.23083974 |
5 | FRK | 3.11454388 |
6 | SIK1 | 2.87646342 |
7 | FES | 2.43802368 |
8 | MST1R | 2.43273481 |
9 | GRK6 | 2.31185916 |
10 | BLK | 2.27036102 |
11 | FLT3 | 2.19004639 |
12 | INSRR | 2.06397648 |
13 | PKN2 | 1.99718123 |
14 | TYK2 | 1.96208166 |
15 | MAPK11 | 1.90801392 |
16 | RIPK1 | 1.78035103 |
17 | ERBB4 | 1.77702099 |
18 | MAP2K3 | 1.76030394 |
19 | PIK3CA | 1.74196126 |
20 | MAP2K4 | 1.69165104 |
21 | PTK6 | 1.60976096 |
22 | PIK3CG | 1.59892313 |
23 | PRPF4B | 1.58048371 |
24 | KIT | 1.57023388 |
25 | MAP3K14 | 1.55701159 |
26 | MAP3K10 | 1.54701186 |
27 | LATS1 | 1.51429136 |
28 | MARK3 | 1.45106931 |
29 | ACVR1B | 1.44773805 |
30 | MAP3K7 | 1.43660511 |
31 | MAP4K1 | 1.42260174 |
32 | FGR | 1.41122785 |
33 | BMPR2 | 1.40262297 |
34 | IKBKB | 1.37336281 |
35 | LCK | 1.37021791 |
36 | HCK | 1.36545529 |
37 | TNK2 | 1.35562686 |
38 | NEK9 | 1.25372333 |
39 | TBK1 | 1.21202659 |
40 | EEF2K | 1.17959336 |
41 | JAK2 | 1.17376685 |
42 | IRAK1 | 1.14392269 |
43 | MAP3K13 | 1.08734480 |
44 | JAK1 | 1.08275343 |
45 | CDK6 | 1.06240461 |
46 | ERBB2 | 1.05070368 |
47 | STK10 | 1.01225768 |
48 | PRKAA2 | 0.97659891 |
49 | RIPK4 | 0.96120472 |
50 | MAP3K6 | 0.95392430 |
51 | NUAK1 | 0.92586561 |
52 | IKBKE | 0.91881996 |
53 | MATK | 0.91381398 |
54 | CSF1R | 0.91122226 |
55 | CDK12 | 0.90672163 |
56 | SCYL2 | 0.89148325 |
57 | MAPK4 | 0.89137443 |
58 | KDR | 0.88514706 |
59 | TIE1 | 0.87832819 |
60 | ABL2 | 0.86971609 |
61 | JAK3 | 0.85318549 |
62 | TRIB3 | 0.85241704 |
63 | BTK | 0.84407079 |
64 | CSK | 0.83500162 |
65 | MAP3K3 | 0.82892215 |
66 | MAP3K11 | 0.82293152 |
67 | MAP2K6 | 0.80277419 |
68 | AKT3 | 0.74339911 |
69 | FGFR3 | 0.73032886 |
70 | ZAP70 | 0.72224336 |
71 | TEC | 0.69324987 |
72 | SGK3 | 0.68810765 |
73 | YES1 | 0.67351823 |
74 | STK4 | 0.67031206 |
75 | CAMK1D | 0.66529677 |
76 | PLK4 | 0.65826601 |
77 | TAOK1 | 0.65679572 |
78 | IRAK3 | 0.65190913 |
79 | PRKG2 | 0.65171496 |
80 | MAP2K2 | 0.64629801 |
81 | TGFBR2 | 0.61850196 |
82 | TESK2 | 0.60802614 |
83 | CDK4 | 0.60391395 |
84 | PRKCQ | 0.60254197 |
85 | STK3 | 0.56755969 |
86 | GRK7 | 0.56559259 |
87 | CHUK | 0.56052831 |
88 | NLK | 0.56047394 |
89 | CLK1 | 0.55814834 |
90 | TXK | 0.54205334 |
91 | DAPK2 | 0.53129768 |
92 | MAP3K5 | 0.51417930 |
93 | PTK2 | 0.50288404 |
94 | IRAK2 | 0.48922994 |
95 | ITK | 0.48439935 |
96 | TGFBR1 | 0.48038548 |
97 | LYN | 0.47178999 |
98 | MAP3K8 | 0.47050600 |
99 | PDK1 | 0.46479577 |
100 | EPHB1 | 0.46324260 |
101 | PRKACG | 0.46211699 |
102 | PDPK1 | 0.43985728 |
103 | MYLK | 0.43973957 |
104 | MST4 | 0.43730012 |
105 | TAF1 | 0.43015202 |
106 | SYK | 0.42967491 |
107 | SGK2 | 0.42793213 |
108 | MAP3K2 | 0.42445545 |
109 | WNK1 | 0.42289459 |
110 | RPS6KC1 | 0.41751400 |
111 | RPS6KL1 | 0.41751400 |
112 | MAP3K1 | 0.41191464 |
113 | FYN | 0.40625473 |
114 | PIM1 | 0.40500149 |
115 | EPHA4 | 0.37916277 |
116 | CDK9 | 0.37855523 |
117 | EPHA3 | 0.37734213 |
118 | RPS6KA6 | 0.37477054 |
119 | TAOK2 | 0.36047239 |
120 | EGFR | 0.35771053 |
121 | IGF1R | 0.35747863 |
122 | HIPK2 | 0.34094982 |
123 | MAP2K1 | 0.32800690 |
124 | CAMKK2 | 0.32528180 |
125 | MAPK3 | 0.32277010 |
126 | DYRK1B | 0.31964852 |
127 | EIF2AK3 | 0.31730184 |
128 | RET | 0.30975430 |
129 | MAPK7 | 0.30480648 |
130 | PRKAA1 | 0.30261286 |
131 | PRKCZ | 0.29584714 |
132 | IRAK4 | 0.29465402 |
133 | RPS6KB1 | 0.29170857 |
134 | RPS6KA4 | 0.28863924 |
135 | GSK3A | 0.28363975 |
136 | MELK | 0.28317226 |
137 | BRD4 | 0.28249321 |
138 | LRRK2 | 0.27414827 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41188771 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65629507 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.60569976 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05826793 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93342657 |
6 | Allograft rejection_Homo sapiens_hsa05330 | 2.78644423 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.73253884 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.73062888 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66616399 |
10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.62073463 |
11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.54267993 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.47697984 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41813140 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.40142328 |
15 | Asthma_Homo sapiens_hsa05310 | 2.36017435 |
16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.35440996 |
17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.35079216 |
18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.30304691 |
19 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.22195883 |
20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18779667 |
21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.12857086 |
22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.12517230 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.99061378 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98614251 |
25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97804347 |
26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96464506 |
27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95917983 |
28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94007722 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.91414671 |
30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89367038 |
31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86072068 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.85999697 |
33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.85486132 |
34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.84144270 |
35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82627431 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81763435 |
37 | Bile secretion_Homo sapiens_hsa04976 | 1.79997197 |
38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76098435 |
39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74802283 |
40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73904183 |
41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73874711 |
42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.72484282 |
43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70053118 |
44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67850706 |
45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67182502 |
46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.63436948 |
47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62479027 |
48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57867174 |
49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56946235 |
50 | Measles_Homo sapiens_hsa05162 | 1.51173579 |
51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50344306 |
52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49535189 |
53 | Tuberculosis_Homo sapiens_hsa05152 | 1.46232472 |
54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44587320 |
55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44534796 |
56 | Platelet activation_Homo sapiens_hsa04611 | 1.43539116 |
57 | ABC transporters_Homo sapiens_hsa02010 | 1.40874184 |
58 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39944014 |
59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32787836 |
60 | Influenza A_Homo sapiens_hsa05164 | 1.31591730 |
61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30595353 |
62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28678390 |
63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28162236 |
64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20757588 |
65 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20604890 |
66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19704699 |
67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19287924 |
68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19286049 |
69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19230664 |
70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18215906 |
71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17006812 |
72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15657918 |
73 | Malaria_Homo sapiens_hsa05144 | 1.10083822 |
74 | Legionellosis_Homo sapiens_hsa05134 | 1.08724964 |
75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06297376 |
76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05987329 |
77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04611415 |
78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04572267 |
79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03932603 |
80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03621221 |
81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00739781 |
82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99115261 |
83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98990599 |
84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98744298 |
85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98168313 |
86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98085633 |
87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.97374355 |
88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96377970 |
89 | Lysine degradation_Homo sapiens_hsa00310 | 0.91912317 |
90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90160963 |
91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89475973 |
92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85790604 |
93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84596023 |
94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81548468 |
95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78556441 |
96 | Hepatitis B_Homo sapiens_hsa05161 | 0.76010470 |
97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75645036 |
98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72996373 |
99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72640713 |
100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71658134 |
101 | Lysosome_Homo sapiens_hsa04142 | 0.71586824 |
102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70729812 |
103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66067559 |
104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65200007 |
105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61516516 |
106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61241076 |
107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60059633 |
108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59900645 |
109 | Phagosome_Homo sapiens_hsa04145 | 0.57118221 |
110 | Apoptosis_Homo sapiens_hsa04210 | 0.56736004 |
111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55786935 |
112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55704246 |
113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50631141 |
114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47066333 |
115 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45127936 |
116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43612305 |
117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42890717 |
118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40376402 |
119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40042735 |
120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40037791 |
121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37190856 |
122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35258558 |
123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33500246 |
124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30923944 |
125 | Shigellosis_Homo sapiens_hsa05131 | 0.30380728 |
126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28016076 |
127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.26868145 |
128 | Insulin resistance_Homo sapiens_hsa04931 | 0.26617513 |
129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20003058 |
130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19044988 |
131 | Mineral absorption_Homo sapiens_hsa04978 | 0.16361980 |
132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15984369 |
133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15498248 |
134 | Prion diseases_Homo sapiens_hsa05020 | 0.14332526 |
135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.09779411 |
136 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08119829 |
137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07757506 |
138 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07412851 |
139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07270920 |
140 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.02408147 |
141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.00430814 |
142 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1410391 |
143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1388386 |
144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1172655 |
145 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1009604 |
146 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1007464 |
147 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1005125 |
148 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0894587 |
149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0881233 |
150 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0875935 |
151 | Pertussis_Homo sapiens_hsa05133 | -0.0682493 |
152 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0653670 |
153 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0513871 |
154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0356670 |
155 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0071838 |
156 | Hepatitis C_Homo sapiens_hsa05160 | -0.0016071 |